These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
272 related items for PubMed ID: 2493514
21. Long-term killing of natural killer-resistant target cells by interferon-alpha-, interferon-gamma-, and interleukin-2-activated natural killer cells. Sarzotti M, Klimpel GR, Baron S. Nat Immun Cell Growth Regul; 1989; 8(2):66-75. PubMed ID: 2503715 [Abstract] [Full Text] [Related]
26. Cytolysis of tumor necrosis factor (TNF)-resistant tumor targets. Differential cytotoxicity of monocytes activated by the interferons, IL-2, and TNF. Philip R. J Immunol; 1988 Feb 15; 140(4):1345-9. PubMed ID: 2449501 [Abstract] [Full Text] [Related]
30. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. Albanesi C, Cavani A, Girolomoni G. J Immunol; 1999 Jan 01; 162(1):494-502. PubMed ID: 9886425 [Abstract] [Full Text] [Related]
31. Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells. Gemlo BT, Palladino MA, Jaffe HS, Espevik TP, Rayner AA. Cancer Res; 1988 Oct 15; 48(20):5864-7. PubMed ID: 3139285 [Abstract] [Full Text] [Related]
32. Effects of biological response modifiers on lung natural killer activity. Lauzon W, Lemaire I. Immunopharmacol Immunotoxicol; 1991 Oct 15; 13(3):237-50. PubMed ID: 1719060 [Abstract] [Full Text] [Related]
36. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production. Handa K, Suzuki R, Matsui H, Shimizu Y, Kumagai K. J Immunol; 1983 Feb 15; 130(2):988-92. PubMed ID: 6294182 [Abstract] [Full Text] [Related]
37. Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin. Bialas T, Kolitz J, Levi E, Polivka A, Oez S, Miller G, Welte K. Cancer Res; 1988 Feb 15; 48(4):891-8. PubMed ID: 3257413 [Abstract] [Full Text] [Related]
39. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity. Gan X, Zhang L, Solomon GF, Bonavida B. Brain Behav Immun; 2002 Jun 15; 16(3):227-46. PubMed ID: 12009684 [Abstract] [Full Text] [Related]
40. Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice. Talmadge JE, Tribble HR, Pennington RW, Phillips H, Wiltrout RH. Cancer Res; 1987 May 15; 47(10):2563-70. PubMed ID: 3105865 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]